- Home
- ENSC vs OCTO Comparison
ENSC vs OCTO Comparison
Compare ENSC & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- OCTO
- Stock Information
- Founded
- ENSC 2003
- OCTO 1966
- Country
- ENSC United States
- OCTO United States
- Employees
- ENSC N/A
- OCTO N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- OCTO
- Sector
- ENSC Health Care
- OCTO
- Exchange
- ENSC Nasdaq
- OCTO Nasdaq
- Market Cap
- ENSC 4.9M
- OCTO 4.2M
- IPO Year
- ENSC N/A
- OCTO N/A
- Fundamental
- Price
- ENSC $2.16
- OCTO $1.23
- Analyst Decision
- ENSC
- OCTO
- Analyst Count
- ENSC 0
- OCTO 0
- Target Price
- ENSC N/A
- OCTO N/A
- AVG Volume (30 Days)
- ENSC 53.2K
- OCTO 11.3K
- Earning Date
- ENSC 08-13-2025
- OCTO 08-13-2025
- Dividend Yield
- ENSC N/A
- OCTO N/A
- EPS Growth
- ENSC N/A
- OCTO N/A
- EPS
- ENSC N/A
- OCTO N/A
- Revenue
- ENSC $6,224,081.00
- OCTO $41,576,562.00
- Revenue This Year
- ENSC N/A
- OCTO N/A
- Revenue Next Year
- ENSC $1,381.48
- OCTO N/A
- P/E Ratio
- ENSC N/A
- OCTO N/A
- Revenue Growth
- ENSC 256.35
- OCTO N/A
- 52 Week Low
- ENSC $1.62
- OCTO $0.98
- 52 Week High
- ENSC $14.67
- OCTO $4.86
- Technical
- Relative Strength Index (RSI)
- ENSC 46.61
- OCTO 47.45
- Support Level
- ENSC $1.97
- OCTO $1.11
- Resistance Level
- ENSC $2.40
- OCTO $1.23
- Average True Range (ATR)
- ENSC 0.16
- OCTO 0.05
- MACD
- ENSC 0.00
- OCTO 0.01
- Stochastic Oscillator
- ENSC 44.19
- OCTO 75.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About OCTO Eightco Holdings Inc.
Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.